{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:40Z","timestamp":1792783420651,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T00:00:00Z","timestamp":1484697600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"None"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s40263-016-0403-y","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T04:47:08Z","timestamp":1484714828000},"page":"87-95","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Diazepam in the Treatment of Moderate to Severe Alcohol Withdrawal"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8082-2068","authenticated-orcid":false,"given":"Steven J.","family":"Weintraub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,18]]},"reference":[{"issue":"4","key":"403_CR1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.20882\/adicciones.40","volume":"26","author":"AM Erdozain","year":"2014","unstructured":"Erdozain AM, Callado LF. Neurobiological alterations in alcohol addiction: a review. Adicciones. 2014;26(4):360\u201370.","journal-title":"Adicciones."},{"issue":"22","key":"403_CR2","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMra1407298","volume":"371","author":"MA Schuckit","year":"2014","unstructured":"Schuckit MA. Recognition and management of withdrawal delirium (Delirium Tremens). N Engl J Med. 2014;371(22):2109\u201313.","journal-title":"N Engl J Med."},{"issue":"5427","key":"403_CR3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/bmj.1.5427.92","volume":"1","author":"G Sereny","year":"1965","unstructured":"Sereny G, Kalant H. Comparative clinical evaluation of chlordiazepoxide and promazine in treatment of alcohol-withdrawal syndrome. Br Med J. 1965;1(5427):92\u20137.","journal-title":"Br Med J."},{"issue":"12","key":"403_CR4","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1176\/ajp.125.12.1640","volume":"125","author":"SC Kaim","year":"1969","unstructured":"Kaim SC, Kaim SC, Klett CJ, Klett CJ, Rothfeld B, Rothfeld B. Treatment of the acute alcohol withdrawal state: a comparison of four drugs. Am J Psychiatry. 1969;125(12):1640\u20136.","journal-title":"Am J Psychiatry."},{"issue":"2","key":"403_CR5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.7326\/0003-4819-82-2-175","volume":"82","author":"WL Thompson","year":"1975","unstructured":"Thompson WL, Johnson AD, Maddrey WL. Diazepam and paraldehyde for treatment of severe delirium tremens. A controlled trial. Ann Intern Med. 1975;82(2):175\u201380.","journal-title":"Ann Intern Med."},{"key":"403_CR6","doi-asserted-by":"publisher","unstructured":"Amato L, Minozzi S, Davoli M. Efficacy and safety of pharmacological interventions for the treatment of the alcohol withdrawal syndrome. Cochrane Database Syst Rev. 2011;6:CD008537. doi: 10.1002\/14651858.CD008537.pub2 .","DOI":"10.1002\/14651858.CD008537.pub2"},{"issue":"11","key":"403_CR7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/j.1552-4604.1972.tb00242.x","volume":"12","author":"DJ Greenblatt","year":"1972","unstructured":"Greenblatt DJ, Greenblatt M. Which drug for alcohol withdrawal? J Clin Pharmacol New Drugs. 1972;12(11):429\u201331.","journal-title":"J Clin Pharmacol New Drugs."},{"issue":"14","key":"403_CR8","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJM197604012941405","volume":"294","author":"EM Sellers","year":"1976","unstructured":"Sellers EM, Kalant H. Alcohol intoxication and withdrawal. N Engl J Med. 1976;294(14):757\u201362.","journal-title":"N Engl J Med."},{"key":"403_CR9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.me.42.020191.001543","volume":"42","author":"MK Romach","year":"1991","unstructured":"Romach MK, Sellers EM. Management of the alcohol withdrawal syndrome. Annu Rev Med. 1991;42:323\u201340.","journal-title":"Annu Rev Med."},{"issue":"5","key":"403_CR10","first-page":"649","volume":"160","author":"AM Holbrook","year":"1999","unstructured":"Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal. Can Med Assoc J. 1999;160(5):649\u201355.","journal-title":"Can Med Assoc J."},{"key":"403_CR11","doi-asserted-by":"publisher","unstructured":"Amato L, Minozzi S, Vecchi S, Davoli M. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev. 2010;3:CD005063. doi: 10.1002\/14651858.CD005063.pub3 .","DOI":"10.1002\/14651858.CD005063.pub3"},{"issue":"5","key":"403_CR12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s40263-014-0163-5","volume":"28","author":"EC Perry","year":"2014","unstructured":"Perry EC. Inpatient management of acute alcohol withdrawal syndrome. CNS Drugs. 2014;28(5):401\u201310.","journal-title":"CNS Drugs."},{"issue":"4","key":"403_CR13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40265-015-0358-1","volume":"75","author":"A Mirijello","year":"2015","unstructured":"Mirijello A, D\u2019Angelo C, Ferrulli A, Vassallo G, Antonelli M, Caputo F, et al. Identification and management of alcohol withdrawal syndrome. Drugs. 2015;75(4):353\u201365.","journal-title":"Drugs."},{"issue":"6","key":"403_CR14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/alcalc\/33.6.563","volume":"33","author":"M Lejoyeux","year":"1998","unstructured":"Lejoyeux M, Solomon J, Ad\u00e8s J. Benzodiazepine treatment for alcohol-dependent patients. Alcohol Alcohol. 1998;33(6):563\u201375.","journal-title":"Alcohol Alcohol."},{"issue":"13","key":"403_CR15","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/archinte.164.13.1405","volume":"164","author":"MF Mayo-Smith","year":"2004","unstructured":"Mayo-Smith MF, Beecher LH, Fischer TL, Gorelick DA, Guillaume JL, Hill A, et al. Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med. 2004;164(13):1405\u201312.","journal-title":"Arch Intern Med."},{"issue":"2","key":"403_CR16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jama.1997.03550020076042","volume":"278","author":"MF Mayo-Smith","year":"1997","unstructured":"Mayo-Smith MF. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA. 1997;278(2):144\u201351.","journal-title":"JAMA."},{"issue":"1","key":"403_CR17","first-page":"52","volume":"6","author":"J Solomon","year":"1983","unstructured":"Solomon J, Rouck LA, Koepke HH. Double-blind comparison of lorazepam and chlordiazepoxide in the treatment of the acute alcohol abstinence syndrome. Clin Ther. 1983;6(1):52\u20138.","journal-title":"Clin Ther."},{"key":"403_CR18","unstructured":"\u00d3Brien JE, Meyer RE, Thoms DC. Double-blind comparison of lorazepam and diazepam in the treatment of the acute alcohol abstinence syndrome. Curr Ther Res Clin Exp. 1983;34(5):825\u201331."},{"issue":"3","key":"403_CR19","first-page":"364","volume":"6","author":"WC Miller","year":"1984","unstructured":"Miller WC, McCurdy L. A double-blind comparison of the efficacy and safety of lorazepam and diazepam in the treatment of the acute alcohol withdrawal syndrome. Clin Ther. 1984;6(3):364\u201371.","journal-title":"Clin Ther."},{"issue":"3","key":"403_CR20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.15288\/jsad.2009.70.467","volume":"70","author":"CN Kumar","year":"2009","unstructured":"Kumar CN, Andrade C, Murthy P. A randomized, double-blind comparison of lorazepam and chlordiazepoxide in patients with uncomplicated alcohol withdrawal. J Stud Alcohol Drugs. 2009;70(3):467\u201374.","journal-title":"J Stud Alcohol Drugs."},{"issue":"5","key":"403_CR21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ajp.2013.05.003","volume":"6","author":"V Rajmohan","year":"2013","unstructured":"Rajmohan V, Sushil K, Mohandas E. A double blind randomised comparison of chlordiazepoxide and lorazepam in alcohol withdrawal. Asian J Psychiatr. 2013;6(5):401\u20133.","journal-title":"Asian J Psychiatr."},{"issue":"3","key":"403_CR22","first-page":"FC10","volume":"9","author":"R Ramanujam","year":"2015","unstructured":"Ramanujam R, Padma L, Swaminath G, Thimmaiah RS. A comparative study of the clinical efficacy and safety of lorazepam and chlordiazepoxide in alcohol dependence syndrome. J Clin Diagn Res. 2015;9(3):FC10-3.","journal-title":"J Clin Diagn Res"},{"issue":"2","key":"403_CR23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1521-0391.2013.00307.x","volume":"22","author":"AJ Muzyk","year":"2013","unstructured":"Muzyk AJ, Leung JG, Nelson S, Embury ER, Jones SR. The role of diazepam loading for the treatment of alcohol withdrawal syndrome in hospitalized patients. Am J Addict. 2013;22(2):113\u20138.","journal-title":"Am J Addict."},{"issue":"2","key":"403_CR24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1001\/archinte.1978.03630260068019","volume":"138","author":"WL Thompson","year":"1978","unstructured":"Thompson WL. Management of alcohol withdrawal syndromes. Arch Intern Med. 1978;138(2):278\u201383.","journal-title":"Arch Intern Med."},{"key":"403_CR25","doi-asserted-by":"publisher","unstructured":"Stehman CR, Mycyk MB. A rational approach to the treatment of alcohol withdrawal in the ED. Am J Emerg Med. 2013;31(4):734\u201342. doi: 10.1016\/j.ajem.2012.12.029 .","DOI":"10.1016\/j.ajem.2012.12.029"},{"key":"403_CR26","unstructured":"Hoffman RS, Weinhousec GL. Management of moderate and severe alcohol withdrawal syndromes. Waltham, MA: UpToDate. http:\/\/www.uptodate.com\/contents\/management-of-moderate-and-severe-alcohol-withdrawal-syndromes . Accessed 27 July 2016."},{"key":"403_CR27","first-page":"117S","volume":"11","author":"LE Hollister","year":"1981","unstructured":"Hollister LE. Benzodiazepines\u2014an overview. Br J Clin Pharmacol. 1981;11:117S\u20139S.","journal-title":"Br J Clin Pharmacol."},{"issue":"1","key":"403_CR28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/BF02439589","volume":"93","author":"RM Arendt","year":"1987","unstructured":"Arendt RM, Greenblatt DJ, Liebisch DC, Luu MD, Paul SM. Determinants of benzodiazepine brain uptake: lipophilicity versus binding affinity. Psychopharmacology (Berl). 1987;93(1):72\u20136.","journal-title":"Psychopharmacology (Berl)."},{"issue":"1","key":"403_CR29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-3565(25)21328-3","volume":"250","author":"DJ Greenblatt","year":"1989","unstructured":"Greenblatt DJ, Ehrenberg BL, Gunderman J, Scavone JM, Tai NT, Harmatz JS, et al. Kinetic and dynamic study of intravenous lorazepam: comparison with intravenous diazepam. J Pharmacol Exp Ther. 1989;250(1):134\u201340.","journal-title":"J Pharmacol Exp Ther."},{"issue":"10","key":"403_CR30","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/bja\/48.10.1017","volume":"48","author":"HW Elliott","year":"1976","unstructured":"Elliott HW. Metabolism of lorazepam. Br J Anaesth. 1976;48(10):1017\u201323.","journal-title":"Br J Anaesth."},{"issue":"5\u20136","key":"403_CR31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/j.1552-4604.1978.tb02448.x","volume":"18","author":"JT Conner","year":"1978","unstructured":"Conner JT, Katz RL, Bellville JW, Graham C, Pagano R, Dorey F. Diazepam and lorazepam for intravenous surgical premedication. J Clin Pharmacol. 1978;18(5\u20136):285\u201392.","journal-title":"J Clin Pharmacol."},{"issue":"5","key":"403_CR32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/bja\/51.5.439","volume":"51","author":"JW Dundee","year":"1979","unstructured":"Dundee JW, McGowan WA, Lilburn JK, McKay AC, Hegarty JE. Comparison of the actions of diazepam and lorazepam. Br J Anaesth. 1979;51(5):439\u201346.","journal-title":"Br J Anaesth."},{"issue":"1","key":"403_CR33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/003693307201700103","volume":"17","author":"JH Brown","year":"1972","unstructured":"Brown JH, Moggey DE, Shane FH. Delirium tremens: a comparison of intravenous treatment with diazepam and chlordiazepoxide. Scott Med J. 1972;17(1):9\u201312.","journal-title":"Scott Med J."},{"issue":"5","key":"403_CR34","first-page":"211","volume":"28","author":"P Hein\u00e4l\u00e4","year":"1990","unstructured":"Hein\u00e4l\u00e4 P, Piepponen T, Heikkinen H. Diazepam loading in alcohol withdrawal: clinical pharmacokinetics. Int J Clin Pharmacol Ther Toxicol. 1990;28(5):211\u20137.","journal-title":"Int J Clin Pharmacol Ther Toxicol."},{"issue":"6","key":"403_CR35","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/TA.0000000000000352","volume":"77","author":"JJ Duby","year":"2014","unstructured":"Duby JJ, Berry AJ, Ghayyem P, Wilson MD, Cocanour CS. Alcohol withdrawal syndrome in critically ill patients: protocolized versus nonprotocolized management. J Trauma Acute Care Surg. 2014;77(6):938\u201343.","journal-title":"J Trauma Acute Care Surg."},{"issue":"3","key":"403_CR36","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/01.CCM.0000256841.28351.80","volume":"35","author":"JA Gold","year":"2007","unstructured":"Gold JA, Rimal B, Nolan A, Nelson LS. A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens. Crit Care Med. 2007;35(3):724\u201330.","journal-title":"Crit Care Med."},{"key":"403_CR37","doi-asserted-by":"crossref","unstructured":"Teboul E, Chouinard G. A guide to benzodiazepine selection. Part I: Pharmacological aspects. Can J Psychiatry. 1990;35(8):700\u201310.","DOI":"10.1177\/070674379003500811"},{"issue":"2","key":"403_CR38","first-page":"214","volume":"13","author":"CE Griffin 3rd","year":"2013","unstructured":"Griffin CE 3rd, Kaye AM, Bueno FR, Kaye AD. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J. 2013;13(2):214\u201323.","journal-title":"Ochsner J."},{"issue":"1","key":"403_CR39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2125.1977.tb00665.x","volume":"4","author":"KA George","year":"1977","unstructured":"George KA, Dundee JW. Relative amnesic actions of diazepam, flunitrazepam and lorazepam in man. Br J Clin Pharmacol. 1977;4(1):45\u201350.","journal-title":"Br J Clin Pharmacol."},{"key":"403_CR40","first-page":"487","volume":"34","author":"DJ Greenblatt","year":"1983","unstructured":"Greenblatt DJ, Divoll M. Diazepam versus lorazepam: relationship of drug distribution to duration of clinical action. Adv Neurol. 1983;34:487\u201391.","journal-title":"Adv Neurol."},{"key":"403_CR41","first-page":"62","volume":"3","author":"DJ Greenblatt","year":"1987","unstructured":"Greenblatt DJ, Friedman HL, Shader RI. Correlating pharmacokinetics and pharmacodynamics of benzodiazepines: problems and assumptions. Psychopharmacol Ser. 1987;3:62\u201371.","journal-title":"Psychopharmacol Ser."},{"issue":"1","key":"403_CR42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/106002809402800114","volume":"28","author":"RD Bird","year":"1994","unstructured":"Bird RD, Makela EH. Alcohol withdrawal: what is the benzodiazepine of choice? Ann Pharmacother. 1994;28(1):67\u201371.","journal-title":"Ann Pharmacother."},{"issue":"5796","key":"403_CR43","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/bmj.1.5796.354","volume":"1","author":"MJ Kendall","year":"1972","unstructured":"Kendall MJ, Clarke SW. Prolonged coma after tetanus. Br Med J. 1972;1(5796):354\u20135.","journal-title":"Br Med J."},{"issue":"16","key":"403_CR44","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1001\/jama.1979.03290420018017","volume":"241","author":"A Kales","year":"1979","unstructured":"Kales A, Scharf MB, Kales JD, Soldatos CR. Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines. JAMA. 1979;241(16):1692\u20135.","journal-title":"JAMA."},{"issue":"2","key":"403_CR45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/clpt.1982.27","volume":"31","author":"MB Scharf","year":"1982","unstructured":"Scharf MB, Kales A, Bixler EO, Jacoby JA, Schweitzer PK. Lorazepam-efficacy, side effects, and rebound phenomena. Clin Pharmacol Ther. 1982;31(2):175\u20139.","journal-title":"Clin Pharmacol Ther."},{"issue":"6","key":"403_CR46","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJM198308113090607","volume":"309","author":"DJ Greenblatt","year":"1983","unstructured":"Greenblatt DJ, Shader RI, Abernethy DR. Drug therapy. Current status of benzodiazepines. N Engl J Med. 1983;309(6):354\u20138.","journal-title":"N Engl J Med."},{"issue":"5","key":"403_CR47","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00004714-198810000-00006","volume":"8","author":"A Kales","year":"1988","unstructured":"Kales A, Soldatos CR, Bixler EO, Kales JD, Vela-Bueno A. Diazepam: effects on sleep and withdrawal phenomena. J Clin Psychopharmacol. 1988;8(5):340\u20136.","journal-title":"J Clin Psychopharmacol."},{"issue":"9","key":"403_CR48","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2105\/AJPH.83.9.1300","volume":"83","author":"DD Hallfors","year":"1993","unstructured":"Hallfors DD, Saxe L. The dependence potential of short half-life benzodiazepines: a meta-analysis. Am J Public Health. 1993;83(9):1300\u20134.","journal-title":"Am J Public Health."},{"issue":"5","key":"403_CR49","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/j.1875-9114.1994.tb02854.x","volume":"14","author":"LL Hoey","year":"1994","unstructured":"Hoey LL, Nahum A, Vance-Bryan K. A prospective evaluation of benzodiazepine guidelines in the management of patients hospitalized for alcohol withdrawal. Pharmacotherapy. 1994;14(5):579\u201385.","journal-title":"Pharmacotherapy."},{"issue":"Suppl 5","key":"403_CR50","first-page":"7","volume":"65","author":"G Chouinard","year":"2004","unstructured":"Chouinard G. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry. 2004;65(Suppl 5):7\u201312.","journal-title":"J Clin Psychiatry."},{"issue":"3","key":"403_CR51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.yco.0000165594.60434.84","volume":"18","author":"H Ashton","year":"2005","unstructured":"Ashton H. The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry. 2005;18(3):249\u201355.","journal-title":"Curr Opin Psychiatry."},{"issue":"4","key":"403_CR52","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0376-8716(86)90095-5","volume":"18","author":"B Ritson","year":"1986","unstructured":"Ritson B, Chick J. Comparison of two benzodiazepines in the treatment of alcohol withdrawal: effects on symptoms and cognitive recovery. Drug Alcohol Depend. 1986;18(4):329\u201334.","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"403_CR53","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0740-5472(93)90005-M","volume":"10","author":"A Hill","year":"1993","unstructured":"Hill A, Williams D. Hazards associated with the use of benzodiazepines in alcohol detoxification. J Subst Abuse Treat. 1993;10(5):449\u201351.","journal-title":"J Subst Abuse Treat."},{"issue":"3","key":"403_CR54","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1530-0277.1995.tb01563.x","volume":"19","author":"MF Mayo-Smith","year":"1995","unstructured":"Mayo-Smith MF, Bernard D. Late-onset seizures in alcohol withdrawal. Alcohol Clin Exp Res. 1995;19(3):656\u20139.","journal-title":"Alcohol Clin Exp Res."},{"issue":"7","key":"403_CR55","first-page":"798","volume":"132","author":"P Devenyi","year":"1985","unstructured":"Devenyi P, Harrison ML. Prevention of alcohol withdrawal seizures with oral diazepam loading. Can Med Assoc J. 1985;132(7):798\u2013800.","journal-title":"Can Med Assoc J."},{"issue":"5","key":"403_CR56","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/cpt1976205571","volume":"20","author":"DR Stanski","year":"1976","unstructured":"Stanski DR, Greenblatt DJ, Selwyn A, Shader RI, Franke K, Koch-Weser J. Plasma and cerebrospinal fluid concentrations of chlordiazepoxide and its metabolites in surgical patients. Clin Pharmacol Ther. 1976;20(5):571\u20138.","journal-title":"Clin Pharmacol Ther."},{"issue":"10","key":"403_CR57","first-page":"486","volume":"16","author":"DJ Greenblatt","year":"1978","unstructured":"Greenblatt DJ, Shader RI, Franke K, Harmatz JS. Pharmacokinetics of chlordiazepoxide and metabolites following single and multiple oral doses. Int J Clin Pharmacol Biopharm. 1978;16(10):486\u201393.","journal-title":"Int J Clin Pharmacol Biopharm."},{"issue":"5","key":"403_CR58","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00003088-197803050-00004","volume":"3","author":"DJ Greenblatt","year":"1978","unstructured":"Greenblatt DJ, Shader RI, MacLeod SM, Sellers EM. Clinical pharmacokinetics of chlordiazepoxide. Clin Pharmacokinet. 1978;3(5):381\u201394.","journal-title":"Clin Pharmacokinet."},{"issue":"1","key":"403_CR59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1176\/ajp.136.1.18","volume":"136","author":"KM Lin","year":"1979","unstructured":"Lin KM, Friedel RO. Relationship of plasma levels of chlordiazepoxide and metabolites to clinical response. Am J Psychiatry. 1979;136(1):18\u201323.","journal-title":"Am J Psychiatry."},{"issue":"1\u20132","key":"403_CR60","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/15563658909038575","volume":"27","author":"EI Minder","year":"1989","unstructured":"Minder EI. Toxicity in a case of acute and massive overdose of chlordiazepoxide and its correlation to blood concentration. J Toxicol Clin Toxicol. 1989;27(1\u20132):117\u201327.","journal-title":"J Toxicol Clin Toxicol."},{"issue":"3","key":"403_CR61","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0091-3057(83)90463-X","volume":"18","author":"SM Sainati","year":"1983","unstructured":"Sainati SM, Lorens SA. Intra-raphe benzodiazepines enhance rat locomotor activity: interactions with GABA. Pharmacol Biochem Behav. 1983;18(3):407\u201314.","journal-title":"Pharmacol Biochem Behav."},{"key":"403_CR62","unstructured":"DrugPatentWatch [database on the Internet]. http:\/\/www.drugpatentwatch.com . Accessed 27 July 2016."},{"key":"403_CR63","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/978-3-319-16976-7_69","volume-title":"The 1980\u2019s: A Decade of Marketing Challenges","author":"B Frew","year":"2015","unstructured":"Frew B, Frew JR, Swift CF. Competition Between Original Brands and Generics in Pharmaceuticals: Analysis and Policy Implications. In: Bellur VV, editor. The 1980\u2019s: A Decade of Marketing Challenges. Cham: Springer International Publishing; 2015. p. 282\u20135."},{"key":"403_CR64","first-page":"141","volume":"74","author":"RI Shader","year":"1979","unstructured":"Shader RI, Greenblatt DJ. Benzodiazepines: some aspects of their clinical pharmacology. Ciba Found Symp. 1979;74:141\u201355.","journal-title":"Ciba Found Symp."},{"issue":"6","key":"403_CR65","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/clpt.1983.256","volume":"34","author":"EM Sellers","year":"1983","unstructured":"Sellers EM, Naranjo CA, Harrison M, Devenyi P, Roach C, Sykora K. Diazepam loading: simplified treatment of alcohol withdrawal. Clin Pharmacol Ther. 1983;34(6):822\u20136.","journal-title":"Clin Pharmacol Ther."},{"key":"403_CR66","first-page":"170","volume":"98","author":"S Manikant","year":"1993","unstructured":"Manikant S, Tripathi BM, Chavan BS. Loading dose diazepam therapy for alcohol withdrawal state. Indian J Med Res. 1993;98:170\u20133.","journal-title":"Indian J Med Res."},{"issue":"2","key":"403_CR67","first-page":"305","volume":"31","author":"IM Salloum","year":"1995","unstructured":"Salloum IM, Cornelius JR, Daley DC, Thase ME. The utility of diazepam loading in the treatment of alcohol withdrawal among psychiatric inpatients. Psychopharmacol Bull. 1995;31(2):305\u201310.","journal-title":"Psychopharmacol Bull."},{"issue":"3","key":"403_CR68","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/oxfordjournals.alcalc.a008147","volume":"31","author":"D Wasilewski","year":"1996","unstructured":"Wasilewski D, Matsumoto H, Kur E, Dziklinska A, Wozny E, Stencka K, et al. Assessment of diazepam loading dose therapy of delirium tremens. Alcohol Alcohol. 1996;31(3):273\u20138.","journal-title":"Alcohol Alcohol."},{"issue":"4","key":"403_CR69","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1521-0391.1996.tb00322.x","volume":"5","author":"M Hyatt","year":"1996","unstructured":"Hyatt M, Cheever T, Eldot R. Diazepam Loading for Alcohol Detoxification. Am J Addict. 1996;5(4):354\u20138.","journal-title":"Am J Addict."},{"issue":"12","key":"403_CR70","first-page":"1533","volume":"118","author":"EM Sellers","year":"1978","unstructured":"Sellers EM. Clinical pharmacology and therapeutics of benzodiazepines. Can Med Assoc J. 1978;118(12):1533\u20138.","journal-title":"Can Med Assoc J."},{"key":"403_CR71","first-page":"91","volume":"89","author":"S Schenker","year":"1978","unstructured":"Schenker S. Effects of liver disease and of aging on the disposition and elimination of sedatives. Trans Am Clin Climatol Assoc. 1978;89:91\u20139.","journal-title":"Trans Am Clin Climatol Assoc."},{"issue":"4","key":"403_CR72","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/clpt.1983.64","volume":"33","author":"HR Ochs","year":"1983","unstructured":"Ochs HR, Greenblatt DJ, Eckardt B, Harmatz JS, Shader RI. Repeated diazepam dosing in cirrhotic patients: cumulation and sedation. Clin Pharmacol Ther. 1983;33(4):471\u20136.","journal-title":"Clin Pharmacol Ther."},{"issue":"4","key":"403_CR73","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2125.1983.tb01529.x","volume":"15","author":"CA Naranjo","year":"1983","unstructured":"Naranjo CA, Busto U, Janecek E, Ruiz I, Roach CA, Kaplan K. An intensive drug monitoring study suggesting possible clinical irrelevance of impaired drug disposition in liver disease. Br J Clin Pharmacol. 1983;15(4):451\u20138.","journal-title":"Br J Clin Pharmacol."},{"issue":"5","key":"403_CR74","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/cpt1978235535","volume":"23","author":"PJ Perry","year":"1978","unstructured":"Perry PJ, Wilding DC, Fowler RC, Hepler CD, Caputo JF. Absorption of oral intramuscular chlordiazepoxide by alcoholics. Clin Pharmacol Ther. 1978;23(5):535\u201341.","journal-title":"Clin Pharmacol Ther."},{"issue":"21","key":"403_CR75","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJM197411212912107","volume":"291","author":"DJ Greenblatt","year":"1974","unstructured":"Greenblatt DJ, Shader RI, Koch-Weser J. Slow absorption of intramuscular chlordiazepoxide. N Engl J Med. 1974;291(21):1116\u20138.","journal-title":"N Engl J Med."},{"issue":"1","key":"403_CR76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1213\/00000539-198301000-00001","volume":"62","author":"M Divoll","year":"1983","unstructured":"Divoll M, Greenblatt DJ, Ochs HR, Shader RI. Absolute bioavailability of oral and intramuscular diazepam: effects of age and sex. Anesth Analg. 1983;62(1):1\u20138.","journal-title":"Anesth Analg."},{"issue":"1","key":"403_CR77","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/jps.2600680119","volume":"68","author":"DJ Greenblatt","year":"1979","unstructured":"Greenblatt DJ, Shader RI, Franke K, MacLaughlin DS, Harmatz JS, Allen MD, et al. Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans. J Pharm Sci. 1979;68(1):57\u201363.","journal-title":"J Pharm Sci."},{"issue":"2","key":"403_CR78","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/jps.2600710227","volume":"71","author":"DJ Greenblatt","year":"1982","unstructured":"Greenblatt DJ, Divoll M, Harmatz JS, Shader RI. Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepam. J Pharm Sci. 1982;71(2):248\u201352.","journal-title":"J Pharm Sci."},{"issue":"3","key":"403_CR79","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/emj.4.3.169","volume":"4","author":"GM Galvin","year":"1987","unstructured":"Galvin GM, Jelinek GA. Midazolam: an effective intravenous agent for seizure control. Arch Emerg Med. 1987;4(3):169\u201372.","journal-title":"Arch Emerg Med."},{"issue":"3","key":"403_CR80","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00003246-198803000-00018","volume":"16","author":"WC Lineaweaver","year":"1988","unstructured":"Lineaweaver WC, Anderson K, Hing DN. Massive doses of midazolam infusion for delirium tremens without respiratory depression. Crit Care Med. 1988;16(3):294\u20135.","journal-title":"Crit Care Med."},{"issue":"1","key":"403_CR81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1288\/00005537-199501000-00004","volume":"105","author":"JP Newman","year":"1995","unstructured":"Newman JP, Terris DJ, Moore M. Trends in the management of alcohol withdrawal syndrome. Laryngoscope. 1995;105(1):1\u20137.","journal-title":"Laryngoscope."},{"issue":"3","key":"403_CR82","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00000542-198503000-00017","volume":"62","author":"JG Reves","year":"1985","unstructured":"Reves JG, Fragen RJ, Vinik HR, Greenblatt DJ. Midazolam: pharmacology and uses. Anesthesiology. 1985;62(3):310\u201324.","journal-title":"Anesthesiology."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-016-0403-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-016-0403-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-016-0403-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T12:00:08Z","timestamp":1749902408000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-016-0403-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,18]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["403"],"URL":"https:\/\/doi.org\/10.1007\/s40263-016-0403-y","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,18]]}}}